Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Trinity Biotech
(NASDAQ:TRIB)
Intraday
$1.90
0.0946
[5.24%]
After-Hours
$1.90
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.90
0.0946
[5.24%]
At close: Apr 16
$1.90
0
[0.00%]
After Hours: 8:26AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Trinity Biotech Stock (NASDAQ:TRIB)
Trinity Biotech Stock (NASDAQ: TRIB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 04, 2024
Trinity Biotech Says It Is Targeting Approximately $20M Of Annualized Run-rate EBITDA On Annualized Run-rate Revenues Of Approximately $75M By Q2, 2025
Benzinga Newsdesk
-
Apr 4, 2024, 7:45AM
Trinity Biotech Q4 EPS $(0.72) Up From $(1.33) YoY, Sales $13.43M Miss $15.00M Estimate
Benzinga Newsdesk
-
Apr 4, 2024, 7:42AM
Earnings Scheduled For April 4, 2024
Benzinga Insights
-
Apr 4, 2024, 5:18AM
Friday, February 23, 2024
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Feb 23, 2024, 8:55AM
Thursday, February 22, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Feb 22, 2024, 7:50PM
Thursday, February 15, 2024
Trinity Biotech Finalizes Effective Date As February 23, 2024 For ADS Ratio Change
Benzinga Newsdesk
-
Feb 15, 2024, 12:36PM
Tuesday, February 13, 2024
Trinity Biotech To Implement ADS Ratio Change From 1 ADS-For-4 Class A Ordinary Shares To 1 ADS-For-20 Class A Ordinary Shares
Benzinga Newsdesk
-
Feb 13, 2024, 9:01AM
Wednesday, February 07, 2024
Trinity Biotech Applied For PLA Code For Early Sjogrens Syndrome Test Panel
Benzinga Newsdesk
-
Feb 7, 2024, 8:34AM
Friday, February 02, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Feb 2, 2024, 4:31PM
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Feb 1, 2024, 8:06AM
Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 1, 2024, 7:51AM
Wednesday, January 31, 2024
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 31, 2024, 1:18PM
Trinity Biotech Q3 2023 Earnings Per ADS $(0.18) Up From $(0.24) YoY; Revenue $14.677M Down From $15.704M YoY
Benzinga Newsdesk
-
Jan 31, 2024, 12:52PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 31, 2024, 12:31PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 31, 2024, 8:05AM
Trinity Biotech Announces Acquisition Of The CGM Assets Of Waveform Technologies, Inc.; Upfront Payment Of $12.5M Cash And 9M ADSs
Benzinga Newsdesk
-
Jan 31, 2024, 7:02AM
Wednesday, December 27, 2023
Trinity Biotech Announces It Has Begun Shipments Of Its New HIV Screening Test, TrinScreen HIV To Kenya
Benzinga Newsdesk
-
Dec 27, 2023, 8:58AM
Monday, December 25, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Dec 25, 2023, 8:05AM
Friday, December 22, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 22, 2023, 12:31PM
Monday, December 18, 2023
Trinity Biotech Promotes John Gillard, its CFO, To President And CEO, Effective Immediately; Des Fitzgerald Named As Interim CFO
Benzinga Newsdesk
-
Dec 18, 2023, 4:34PM
Friday, December 08, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Dec 8, 2023, 4:30PM
Wednesday, November 29, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 29, 2023, 8:06AM
Tuesday, November 28, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Nov 28, 2023, 4:31PM
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement For Minimum Market Value Of Publicly Held Shares
Benzinga Newsdesk
-
Nov 28, 2023, 4:09PM
Wednesday, October 11, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 11, 2023, 9:06AM
Tuesday, October 03, 2023
Trinity Biotech Q2 EPADS $(0.16) Misses $(0.09) Estimate, Sales $13.90M Beat $13.50M Estimate
Benzinga Newsdesk
-
Oct 3, 2023, 9:17AM
McCormick, Delta Apparel And 3 Stocks To Watch Heading Into Tuesday
Lisa Levin
-
Oct 3, 2023, 4:13AM
Investor Fear Eases Slightly; US Manufacturing PMI Tops Estimates
Lisa Levin
-
Oct 3, 2023, 2:58AM
Monday, October 02, 2023
Earnings Outlook For Trinity Biotech
Benzinga Insights
-
Oct 2, 2023, 10:00AM
Monday, September 11, 2023
Trinity Biotech Gets Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
Benzinga Newsdesk
-
Sep 11, 2023, 4:51PM
Monday, September 04, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Sep 4, 2023, 5:31PM
Friday, September 01, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Sep 1, 2023, 5:31PM
Monday, August 07, 2023
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Aug 7, 2023, 1:28PM
Trinity Biotech Announces That It Has Received 510(k) Clearance From The FDA For The Premier Resolution System
Benzinga Newsdesk
-
Aug 7, 2023, 8:01AM
Thursday, July 20, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jul 20, 2023, 5:32PM
Wednesday, July 19, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Jul 19, 2023, 5:32PM
Thursday, July 06, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jul 6, 2023, 1:37PM
Trinity Biotech Q1 EPADS $(0.15) Up From $(0.50) YoY, Sales $14.83M Down From $15.68M YoY
Benzinga Newsdesk
-
Jul 6, 2023, 9:49AM
Levi Strauss, VBI Vaccines And 3 Stocks To Watch Heading Into Thursday
Lisa Levin
-
Jul 6, 2023, 4:18AM
Investor Optimism Improves Slightly Following Fed Minutes
Lisa Levin
-
Jul 6, 2023, 2:59AM
Wednesday, July 05, 2023
Trinity Biotech's Earnings Outlook
Benzinga Insights
-
Jul 5, 2023, 10:00AM
Friday, May 05, 2023
Trinity Biotech Regains Compliance With Nasdaq Minimum Closing Bid Price Rule
Benzinga Newsdesk
-
May 5, 2023, 8:09AM
Monday, April 24, 2023
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
Michael Horton
-
Apr 24, 2023, 5:51PM
Thursday, April 20, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Apr 20, 2023, 1:31PM
Why Trinity Biotech Stock Is Moving Up Today
Sean Torres
-
Apr 20, 2023, 12:03PM
Trinity Biotech shares are trading higher after the company announced the sale of its Fitzgerald Industries life sciences supply business for cash proceeds of ~$30 million.
Michael Horton
-
Apr 20, 2023, 10:57AM
Trinity Biotech Announces $30M Sale Of Life Sciences Supply Business To Biosynth
Benzinga Newsdesk
-
Apr 20, 2023, 8:34AM
Monday, April 10, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Apr 10, 2023, 1:48PM
Friday, March 31, 2023
Trinity Biotech Filed Prospectus Relating To Resale, From Time To Time, By Selling Shareholder Of Up To 2.5M M ADSs
Charles Gross
-
Mar 31, 2023, 7:36AM
Thursday, March 23, 2023
Trinity Biotech Q4 Loss Per ADS $(0.27) Down From $(0.06) YoY, Sales $18.04M Beat $18.00M Estimate
Benzinga Newsdesk
-
Mar 23, 2023, 8:55AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch